共 50 条
- [21] CYP2C19 genotyping and associated mephenytoin hydroxylation polymorphism in a Canadian Inuit population PHARMACOGENETICS, 1996, 6 (04): : 329 - 339
- [22] A new genetic defect in human CYP2C19:: Mutation of the initiation codon is responsible for poor metabolism of S-mephenytoin JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1998, 284 (01): : 356 - 361
- [26] Assessment of urinary mephenytoin metrics to phenotype for CYP2C19 and CYP2B6 activity European Journal of Clinical Pharmacology, 2008, 64 : 387 - 398
- [27] Individual difference in drug metabolism and disposition:: Toxicological significance of genotypes and phenotypes of S-mephenytoin 4′-hydroxylase (CYP2C19) PROGRESS IN FORENSIC GENETICS 9, 2003, 1239 : 589 - 592
- [30] The effect of the CYP2C19 genotype on the hydroxylation index of omeprazole in South Indians European Journal of Clinical Pharmacology, 2005, 61 : 19 - 23